Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Peschel

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Gynecologic Oncology|June 1, 1987
Prognostic factors and sites of failure in FIGO Stage I, Grade 3 endometrial carcinomaS K Chambers, D S Kapp, R E Peschel, et al.
International Journal of Cancer|March 22, 2000
PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patientsR E Peschel, T J Robnett, D Hesse, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2010
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapyAyal A Aizer, Nicole S Anderson, Steven C Oh, et al.
Oncology Research|January 1, 1993
A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancerJ R Murren, S Ganpule, R Papac, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapyB C Turner, J P Knisely, B M Kacinski, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Gynecologic Oncology|June 1, 1987
Prognostic factors and sites of failure in FIGO Stage I, Grade 3 endometrial carcinomaS K Chambers, D S Kapp, R E Peschel, et al.
International Journal of Cancer|March 22, 2000
PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patientsR E Peschel, T J Robnett, D Hesse, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2010
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapyAyal A Aizer, Nicole S Anderson, Steven C Oh, et al.
Oncology Research|January 1, 1993
A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancerJ R Murren, S Ganpule, R Papac, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapyB C Turner, J P Knisely, B M Kacinski, et al.
Pageof 6